首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

市場調查報告書

商品編碼

1935255

經導管主動脈瓣置換術市場依手術方式、器械、最終用戶和地區分類

Transcatheter Aortic Valve Replacement Market, By Procedure Type, By Device Type, By End User, By Geography

出版日期: 2026年01月16日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

經導管主動脈瓣置換術(TAVR) 市場預計在 2026 年達到 81.2 億美元，預計到 2033 年將達到 137.6 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 8.2%。

報告內容		報告詳情
基準年：	2025	2026年市場規模：	81.2億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	8.20%	2033 年的預測值：	137.6億美元

隨著醫療機構逐漸接受經導管主動脈瓣置換術(TAVR) 作為治療主動脈瓣狹窄的微創治療方法方案，TAVR 市場正在迅速擴張。由於 TAVR 具有恢復時間短、併發症率低、生活品質高等優勢，醫生擴大向手術風險較高或中等的患者推薦 TAVR。心血管疾病盛行率的不斷上升以及人口老化，正在推動對創新微創心臟治療方法的需求。

醫療技術的進步，包括新一代瓣膜和改良的輸送系統，透過提高手術的安全性和有效性，正在推動市場成長。器械製造商和醫療服務提供者正積極致力於透過持續創新和專業培訓，擴大醫療服務的可近性並最佳化患者治療效果。人們對早期診斷的意識提升，加上微創手術的廣泛應用，正在打造一個充滿活力的市場，該市場強調以患者為中心的護理，並在全球範圍內拓展主動脈瓣疾病的治療選擇。

市場動態

經導管主動脈瓣置換術（TAVR）市場成長的主要原因是主動脈瓣狹窄盛行率的上升以及人們對微創手術而非傳統開胸手術的偏好日益增強。人口老化和全球心血管疾病盛行率的上升，使得人們對有效且創傷較小的治療方案的需求日益迫切。患者和醫療服務提供者都在積極尋求能夠縮短復原時間、降低併發症風險並改善長期療效的解決方案，這使得TAVR成為高風險和中度風險患者的首選。

技術創新正在積極改變市場格局。製造商正迅速推出新一代經導管瓣膜、先進的輸送系統和改進的成像技術，從而提高手術的準確性、安全性和有效性。這些創新使醫生能夠治療更廣泛的患者群體，包括那些解剖結構複雜的患者，從而擴大了潛在患者群體。醫療機構也正在實施專門的培訓計畫並升級基礎設施，以支援更高的技術應用率和更有效率的手術流程。

儘管TAVR市場成長迅速，但仍面臨諸多挑戰，例如手術費用高昂、部分地區報銷限制以及新興市場准入有限。患者的個別因素，例如合併症和解剖結構限制，需要周密的計劃和個別化的治療方案。然而，人們對早期診斷的認知不斷提高、持續的臨床研究以及以患者為中心的創新理念，都在推動市場成長，為TAVR在全球範圍內成為安全有效的主動脈瓣疾病治療方法創造了良好的發展環境。

本次調查的主要特點

本報告對經導管主動脈瓣置換術(TAVR) 市場進行了詳細分析，以 2025 年為基準年，給出了預測期 (2026-2033) 內的市場規模（十億美元）和復合年成長率 (%)。
我們也將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業的競爭策略的重要見解。
該研究根據以下參數對經導管主動脈瓣置換術市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將有助於負責人和經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
這份經導管主動脈瓣置換術市場報告面向該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過經導管主動脈瓣置換術市場分析中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

熱圖分析
市佔率分析（3x3矩陣）
公司簡介
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- St. Jude Medical
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE &Co. KG.
- Cook Medical

第9章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第10章各節

參考
調查方法

簡介目錄

Product Code: CMI7525

Transcatheter Aortic Valve Replacement Market is estimated to be valued at USD 8.12 Bn in 2026 and is expected to reach USD 13.76 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.12 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.20%	2033 Value Projection:	USD 13.76 Bn

The transcatheter aortic valve replacement (TAVR) market is expanding rapidly as healthcare providers adopt this minimally invasive alternative to traditional open-heart surgery for treating aortic valve stenosis. Physicians increasingly recommend TAVR for patients at high or intermediate surgical risk because it reduces recovery times, lowers complication rates, and improves quality of life. Rising rates of cardiovascular diseases, along with an aging population, are driving demand for innovative, less invasive cardiac interventions.

Medical technology advancements, including next-generation valves and enhanced delivery systems, are strengthening market growth by improving procedural safety and effectiveness. Device manufacturers and healthcare providers are actively working to increase accessibility and optimize patient outcomes through continuous innovation and professional training. Growing awareness of early diagnosis, combined with wider adoption of minimally invasive procedures, is creating a dynamic market that emphasizes patient-centered care and expands treatment options for aortic valve disease worldwide.

Market Dynamics

The TAVR market grows primarily due to the rising prevalence of aortic valve stenosis and the increasing preference for minimally invasive procedures over traditional open-heart surgery. Aging populations and the global rise in cardiovascular diseases are creating strong demand for effective, less invasive treatment options. Patients and healthcare providers are actively seeking solutions that shorten recovery times, reduce complication risks, and improve long-term outcomes, making TAVR the preferred choice for high- and intermediate-risk patients.

Technological innovations are actively transforming the market. Manufacturers are launching next-generation transcatheter valves, advanced delivery systems, and improved imaging techniques that enhance procedural accuracy, safety, and effectiveness. These innovations allow physicians to treat a broader range of patients, including those with complex anatomies, expanding the potential patient base. Healthcare facilities are also adopting professional training programs and upgrading infrastructure to support higher adoption rates and improve procedural efficiency.

Despite its rapid growth, the TAVR market faces challenges such as high procedural costs, reimbursement limitations in some regions, and restricted access in emerging markets. Patient-specific factors, including comorbidities and anatomical constraints, require careful planning and tailored treatment approaches. Nevertheless, rising awareness of early diagnosis, ongoing clinical research, and a focus on patient-centered innovations continue to propel market growth, creating a dynamic environment that advances TAVR as a safe and effective treatment for aortic valve disease worldwide.

Key Features of the Study

This report provides in-depth analysis of the Transcatheter Aortic Valve Replacement Market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Transcatheter Aortic Valve Replacement Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Edwards Lifesciences Corp., Medtronic Plc., Abbott Laboratories., Boston Scientific Corp., MicroPort Scientific Corp., JenaValve Technology GmbH., Cardiovascular Systems, Inc., Symetis SA., Lepu Medical Technology Co., Ltd., Terumo Corporation., St. Jude Medical (now part of Abbott)., AtriCure, Inc., Vascular Solutions, Inc., Biotronik SE & Co. KG., and Cook Medical
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Transcatheter Aortic Valve Replacement Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Transcatheter Aortic Valve Replacement Market

Market Segmentation

By Procedure Type Insights
- Transfemoral
- Transapical
- Other Approaches
By Device Type Insights
- Balloon-Expandable Valves
- Self-Expanding Valves
By End User Insights
- Hospitals
- Ambulatory Surgical Centers
- Independent Cardiac Catheterization Labs
- Others
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Edwards Lifesciences Corp.
- Medtronic Plc.
- Abbott Laboratories.
- Boston Scientific Corp.
- MicroPort Scientific Corp.
- JenaValve Technology GmbH.
- Cardiovascular Systems, Inc.
- Symetis SA.
- Lepu Medical Technology Co., Ltd.
- Terumo Corporation.
- Jude Medical (now part of Abbott).
- AtriCure, Inc.
- Vascular Solutions, Inc.
- Biotronik SE & Co. KG.
- Cook Medical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Procedure Type
- Market Snippet, By Device Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Transcatheter Aortic Valve Replacement Market, By Procedure Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Transfemoral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Transapical
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Other Approaches
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Transcatheter Aortic Valve Replacement Market, By Device Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Balloon-Expandable Valves
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Self-Expanding Valves
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Transcatheter Aortic Valve Replacement Market, By End User, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Ambulatory Surgical Centers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Independent Cardiac Catheterization Labs
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Transcatheter Aortic Valve Replacement Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Procedure Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Device Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Edwards Lifesciences Corp.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Medtronic Plc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Abbott Laboratories
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Boston Scientific Corp.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- MicroPort Scientific Corp.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- JenaValve Technology GmbH
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cardiovascular Systems, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Symetis SA.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Lepu Medical Technology Co., Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Terumo Corporation.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- St. Jude Medical
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- AtriCure, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Vascular Solutions, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Biotronik SE & Co. KG.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cook Medical
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates